{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:49:03Z","timestamp":1785761343926,"version":"3.56.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00349501"],"award-info":[{"award-number":["RS-2024-00349501"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Osteoblast development must be precisely regulated, as insufficient bone formation results in low bone mass and skeletal fragility, whereas excessive osteogenesis drives heterotopic ossification (HO), the ectopic formation of bone in soft tissues. Here, we identify the deubiquitinating enzyme ubiquitin-specific peptidase 24 (USP24) as a key regulator of both physiological and pathological ossification. USP24 is highly expressed in skeletal tissues, where it promotes osteoblast development by stabilizing STAT2 through deubiquitination. Loss of USP24 reduces osteoblast differentiation and bone formation, an effect mirrored by STAT2 deficiency. Beyond physiologic bone, USP24 and STAT2 are also strongly expressed in heterotopic bones from patients with HO. In a fibrodysplasia ossificans progressiva (FOP) mouse model, recombinant adeno-associated virus (rAAV)-mediated silencing of\n                    <jats:italic>Usp24<\/jats:italic>\n                    markedly diminished HO pathogenesis and reduced STAT2 protein levels in HO lesions. Consistently, USP24 deficiency attenuated activin A-induced bone morphogenetic protein (BMP) signaling and osteogenesis, with comparable effects observed upon\n                    <jats:italic>Stat2<\/jats:italic>\n                    silencing. Together, these findings uncover a previously unrecognized role for USP24-STAT2 signaling in osteoblast differentiation and HO, highlighting bone-targeted USP24-STAT2 inhibition as a potential therapeutic strategy for pathologic bone formation.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08888-7","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T17:14:08Z","timestamp":1780161248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP24-dependent STAT2 stabilization mediates physiologic and pathologic bone formation"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-4293","authenticated-orcid":false,"given":"Jung-Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Suk","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Mi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong-Chan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2110-0559","authenticated-orcid":false,"given":"Kwang Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadatoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom-Jik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0097-9012","authenticated-orcid":false,"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-3293","authenticated-orcid":false,"given":"Jae-Hyuck","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"8888_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev-physiol-021119-034425","volume":"82","author":"NA Sims","year":"2020","unstructured":"Sims NA, Martin TJ. Osteoclasts provide coupling signals to osteoblast lineage cells through multiple mechanisms. Annu Rev Physiol. 2020;82:507\u201329.","journal-title":"Annu Rev Physiol"},{"key":"8888_CR2","doi-asserted-by":"publisher","first-page":"2073.","DOI":"10.3390\/cells9092073","volume":"9","author":"JM Kim","year":"2020","unstructured":"Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH. Osteoblast-osteoclast communication and bone homeostasis. Cells. 2020;9:2073.","journal-title":"Cells"},{"key":"8888_CR3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41580-020-00279-w","volume":"21","author":"A Salhotra","year":"2020","unstructured":"Salhotra A, Shah HN, Levi B, Longaker MT. Mechanisms of bone development and repair. Nat Rev Mol Cell Biol. 2020;21:696\u2013711.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8888_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/jor.22500","volume":"32","author":"X Liu","year":"2014","unstructured":"Liu X, Kang H, Shahnazari M, Kim H, Wang L, Larm O, et al. A novel mouse model of trauma-induced heterotopic ossification. J Orthop Res. 2014;32:183\u20138.","journal-title":"J Orthop Res"},{"key":"8888_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.sc.3101309","volume":"40","author":"AA van Kuijk","year":"2002","unstructured":"van Kuijk AA, Geurts AC, van Kuppevelt HJ. Neurogenic heterotopic ossification in spinal cord injury. Spinal Cord. 2002;40:313\u201326.","journal-title":"Spinal Cord"},{"key":"8888_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/0269215507075260","volume":"21","author":"HT Hendricks","year":"2007","unstructured":"Hendricks HT, Geurts AC, van Ginneken BC, Heeren AJ, Vos PE. Brain injury severity and autonomic dysregulation accurately predict heterotopic ossification in patients with traumatic brain injury. Clin Rehabil. 2007;21:545\u201353.","journal-title":"Clin Rehabil"},{"key":"8888_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trsl.2017.06.004","volume":"186","author":"D Dey","year":"2017","unstructured":"Dey D, Wheatley BM, Cholok D, Agarwal S, Yu PB, Levi B. The traumatic bone: trauma-induced heterotopic ossification. Transl Res. 2017;186:95\u2013111.","journal-title":"Transl Res"},{"key":"8888_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/jbmr.1562","volume":"27","author":"MN Wosczyna","year":"2012","unstructured":"Wosczyna MN, Biswas AA, Cogswell CA, Goldhamer DJ. Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification. J Bone Min Res. 2012;27:1004\u201317.","journal-title":"J Bone Min Res"},{"key":"8888_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.berh.2007.11.007","volume":"22","author":"FS Kaplan","year":"2008","unstructured":"Kaplan FS, Le Merrer M, Glaser DL, Pignolo RJ, Goldsby RE, Kitterman JA, et al. Fibrodysplasia ossificans progressiva. Best Pr Res Clin Rheumatol. 2008;22:191\u2013205.","journal-title":"Best Pr Res Clin Rheumatol"},{"key":"8888_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.molmed.2024.08.010","volume":"31","author":"FS Kaplan","year":"2025","unstructured":"Kaplan FS, Shore EM, Pignolo RJ. Fibrodysplasia ossificans progressiva emerges from obscurity. Trends Mol Med. 2025;31:106\u201316.","journal-title":"Trends Mol Med"},{"key":"8888_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01983-2","volume":"16","author":"RJ Pignolo","year":"2021","unstructured":"Pignolo RJ, Hsiao EC, Baujat G, Lapidus D, Sherman A, Kaplan FS. Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization. Orphanet J Rare Dis. 2021;16:350.","journal-title":"Orphanet J Rare Dis"},{"key":"8888_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/jbmr.2728","volume":"31","author":"RJ Pignolo","year":"2016","unstructured":"Pignolo RJ, Bedford-Gay C, Liljesthrom M, Durbin-Johnson BP, Shore EM, Rocke DM, et al. The natural history of flare-ups in fibrodysplasia ossificans progressiva (fop): a comprehensive Global assessment. J Bone Min Res. 2016;31:650\u20136.","journal-title":"J Bone Min Res"},{"key":"8888_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","volume":"20","author":"MJ Clague","year":"2019","unstructured":"Clague MJ, Urbe S, Komander D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat Rev Mol Cell Biol. 2019;20:338\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8888_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16038-6","volume":"11","author":"JM Kim","year":"2020","unstructured":"Kim JM, Yang YS, Park KH, Ge X, Xu R, Li N, et al. A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation. Nat Commun. 2020;11:2289.","journal-title":"Nat Commun"},{"key":"8888_CR15","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1038\/s41418-021-00778-z","volume":"28","author":"SA Wang","year":"2021","unstructured":"Wang SA, Young MJ, Wang YC, Chen SH, Liu CY, Lo YA, et al. USP24 promotes drug resistance during cancer therapy. Cell Death Differ. 2021;28:2690\u2013707.","journal-title":"Cell Death Differ"},{"key":"8888_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06178-1","volume":"9","author":"YC Wang","year":"2018","unstructured":"Wang YC, Wu YS, Hung CY, Wang SA, Young MJ, Hsu TI, et al. USP24 induces IL-6 in the tumor-associated microenvironment by stabilizing p300 and beta-TrCP and promotes cancer malignancy. Nat Commun. 2018;9:3996.","journal-title":"Nat Commun"},{"key":"8888_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.celrep.2014.12.024","volume":"10","author":"L Zhang","year":"2015","unstructured":"Zhang L, Nemzow L, Chen H, Lubin A, Rong X, Sun Z, et al. The deubiquitinating enzyme USP24 is a regulator of the UV damage response. Cell Rep. 2015;10:140\u20137.","journal-title":"Cell Rep"},{"key":"8888_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1158\/0008-5472.CAN-20-1777","volume":"81","author":"T Bedekovics","year":"2021","unstructured":"Bedekovics T, Hussain S, Zhang Y, Ali A, Jeon YJ, Galardy PJ. USP24 is a cancer-associated ubiquitin hydrolase, a novel tumor suppressor, and a chromosome instability gene deleted in neuroblastoma. Cancer Res. 2021;81:1321\u201331.","journal-title":"Cancer Res"},{"key":"8888_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41568-022-00537-3","volume":"23","author":"YJ Li","year":"2023","unstructured":"Li YJ, Zhang C, Martincuks A, Herrmann A, Yu H. STAT proteins in cancer: orchestration of metabolism. Nat Rev Cancer. 2023;23:115\u201334.","journal-title":"Nat Rev Cancer"},{"key":"8888_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.bone.2006.02.074","volume":"39","author":"S Itoh","year":"2006","unstructured":"Itoh S, Udagawa N, Takahashi N, Yoshitake F, Narita H, Ebisu S, et al. A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone. 2006;39:505\u201312.","journal-title":"Bone"},{"key":"8888_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.bone.2011.04.020","volume":"49","author":"H Zhou","year":"2011","unstructured":"Zhou H, Newnum AB, Martin JR, Li P, Nelson MT, Moh A, et al. Osteoblast\/osteocyte-specific inactivation of Stat3 decreases load-driven bone formation and accumulates reactive oxygen species. Bone. 2011;49:404\u201311.","journal-title":"Bone"},{"key":"8888_CR22","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s12276-020-00506-6","volume":"52","author":"CJ Lee","year":"2020","unstructured":"Lee CJ, An HJ, Cho ES, Kang HC, Lee JY, Lee HS, et al. Stat2 stability regulation: an intersection between immunity and carcinogenesis. Exp Mol Med. 2020;52:1526\u201336.","journal-title":"Exp Mol Med"},{"key":"8888_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cytogfr.2008.11.002","volume":"19","author":"Y Luan","year":"2008","unstructured":"Luan Y, Lengyel P, Liu CJ. p204, a p200 family protein, as a multifunctional regulator of cell proliferation and differentiation. Cytokine Growth Factor Rev. 2008;19:357\u201369.","journal-title":"Cytokine Growth Factor Rev"},{"key":"8888_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12929-025-01148-4","volume":"32","author":"B Ning","year":"2025","unstructured":"Ning B, Wang SA, Young MJ, Chen YC, Hung Y, Huong TT, et al. USP24 upregulation stabilizes PKA-Calpha to promote lipogenesis, inflammation, and fibrosis during MASH progression. J Biomed Sci. 2025;32:54.","journal-title":"J Biomed Sci"},{"key":"8888_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38:525\u20137.","journal-title":"Nat Genet"},{"key":"8888_CR26","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bone.2008.05.013","volume":"43","author":"EM Shore","year":"2008","unstructured":"Shore EM, Kaplan FS. Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone. 2008;43:427\u201333.","journal-title":"Bone"},{"key":"8888_CR27","doi-asserted-by":"publisher","first-page":"630.","DOI":"10.3390\/biomedicines9060630","volume":"9","author":"H Lyu","year":"2021","unstructured":"Lyu H, Elkins CM, Pierce JL, Serezani CH, Perrien DS. MyD88 is not required for muscle injury-induced endochondral heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva. Biomedicines. 2021;9:630.","journal-title":"Biomedicines"},{"key":"8888_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33956-9","volume":"13","author":"YS Yang","year":"2022","unstructured":"Yang YS, Kim JM, Xie J, Chaugule S, Lin C, Ma H, et al. Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery. Nat Commun. 2022;13:6175.","journal-title":"Nat Commun"},{"key":"8888_CR29","doi-asserted-by":"publisher","first-page":"e160773","DOI":"10.1172\/JCI160773","volume":"132","author":"MT Collins","year":"2022","unstructured":"Collins MT. Twists in the fibrodysplasia ossificans progressiva story challenge and expand our understanding of BMP biology. J Clin Investig. 2022;132:e160773","journal-title":"J Clin Investig"},{"key":"8888_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41536-021-00178-4","volume":"6","author":"Y Huang","year":"2021","unstructured":"Huang Y, Wang X, Zhou D, Zhou W, Dai F, Lin H. Macrophages in heterotopic ossification: from mechanisms to therapy. NPJ Regen Med. 2021;6:70.","journal-title":"NPJ Regen Med"},{"key":"8888_CR31","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s11684-024-1075-5","volume":"18","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang L, Wang G, Zhao W, Liang C, Tang Y, et al. Single-cell transcriptome profiling identifies the activation of type I interferon signaling in ossified posterior longitudinal ligament. Front Med. 2024;18:1087\u201399.","journal-title":"Front Med"},{"key":"8888_CR32","doi-asserted-by":"crossref","unstructured":"Barruet E, Morales BM, Cain CJ, Ton AN, Wentworth KL, Chan TV, et al. NF-kappaB\/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification. JCI Insight. 2018;3:e122958.","DOI":"10.1172\/jci.insight.122958"},{"key":"8888_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ocl.2016.08.009","volume":"48","author":"WR Barfield","year":"2017","unstructured":"Barfield WR, Holmes RE, Hartsock LA. Heterotopic ossification in trauma. Orthop Clin North Am. 2017;48:35\u201346.","journal-title":"Orthop Clin North Am"},{"key":"8888_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trsl.2017.06.004","volume":"186","author":"D Dey","year":"2017","unstructured":"Dey D, Wheatley BM, Cholok D, Agarwal S, Yu PB, Levi B, et al. The traumatic bone: trauma-induced heterotopic ossification. Transl Res. 2017;186:95\u2013111.","journal-title":"Transl Res"},{"key":"8888_CR35","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/bcp.13823","volume":"85","author":"KL Wentworth","year":"2019","unstructured":"Wentworth KL, Masharani U, Hsiao EC. Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva. Br J Clin Pharmacol. 2019;85:1180\u20137.","journal-title":"Br J Clin Pharmacol"},{"key":"8888_CR36","volume":"9","author":"EC Hsiao","year":"2025","unstructured":"Hsiao EC, Pacifici M. Palovarotene (Sohonos), a synthetic retinoid for reducing new heterotopic ossification in fibrodysplasia ossificans progressiva: history, present, and future. JBMR. 2025;9:ziae147.","journal-title":"JBMR"},{"key":"8888_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41587-020-00756-9","volume":"39","author":"CP Venditti","year":"2021","unstructured":"Venditti CP. Safety questions for AAV gene therapy. Nat Biotechnol. 2021;39:24\u20136.","journal-title":"Nat Biotechnol"},{"key":"8888_CR38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/gt.2008.170","volume":"16","author":"L Vandenberghe","year":"2009","unstructured":"Vandenberghe L, Wilson J, Gao G. Tailoring the AAV vector capsid for gene therapy. Gene Ther. 2009;16:311\u20139.","journal-title":"Gene Ther"},{"key":"8888_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature04791","volume":"441","author":"D Grimm","year":"2006","unstructured":"Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, et al. Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways. Nature. 2006;441:537\u201341.","journal-title":"Nature"},{"key":"8888_CR40","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1073\/pnas.0801775105","volume":"105","author":"JL McBride","year":"2008","unstructured":"McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA. 2008;105:5868\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8888_CR41","unstructured":"Xie J, Tai PWL, Brown A, Li C, Zamore PD, Gao G. A Novel rAAV-amiRNA Platform Enables Potent In Vivo Gene Silencing and a Ten-Fold Enhancement of On-Target Specificity over Conventional shRNA Vectors. American Society of Gene and Cell Therapy 21st Annual Meeting; May 16-19; Chicago, IL. 2018."},{"key":"8888_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10809-6","volume":"10","author":"YS Yang","year":"2019","unstructured":"Yang YS, Xie J, Wang D, Kim JM, Tai PWL, Gravallese E, et al. Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis. Nat Commun. 2019;10:2958.","journal-title":"Nat Commun"},{"key":"8888_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34694-8","volume":"13","author":"C Lin","year":"2022","unstructured":"Lin C, Yang Q, Guo D, Xie J, Yang YS, Chaugule S, et al. Impaired mitochondrial oxidative metabolism in skeletal progenitor cells leads to musculoskeletal disintegration. Nat Commun. 2022;13:6869.","journal-title":"Nat Commun"},{"key":"8888_CR44","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"C Zincarelli","year":"2008","unstructured":"Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 2008;16:1073\u201380.","journal-title":"Mol Ther"},{"key":"8888_CR45","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1182\/blood-2014-10-605584","volume":"125","author":"LF Peterson","year":"2015","unstructured":"Peterson LF, Sun H, Liu Y, Potu H, Kandarpa M, Ermann M, et al. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies. Blood. 2015;125:3588\u201397.","journal-title":"Blood"},{"key":"8888_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt4258","volume":"11","author":"HC Hsieh","year":"2025","unstructured":"Hsieh HC, Young MJ, Chen KY, Su WC, Lin CC, Yen YT, et al. Deubiquitinase USP24, activated by IL-6\/STAT3 enhances PD-1 protein stability and suppresses T cell antitumor response. Sci Adv. 2025;11:eadt4258.","journal-title":"Sci Adv"},{"key":"8888_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/15548627.2019.1598754","volume":"16","author":"JA Thayer","year":"2020","unstructured":"Thayer JA, Awad O, Hegdekar N, Sarkar C, Tesfay H, Burt C, et al. The PARK10 gene USP24 is a negative regulator of autophagy and ULK1 protein stability. Autophagy. 2020;16:140\u201353.","journal-title":"Autophagy"},{"key":"8888_CR48","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41418-024-01277-7","volume":"31","author":"MJ Young","year":"2024","unstructured":"Young MJ, Wang SA, Chen YC, Liu CY, Hsu KC, Tang SW, et al. USP24-i-101 targeting of USP24 activates autophagy to inhibit drug resistance acquired during cancer therapy. Cell Death Differ. 2024;31:574\u201391.","journal-title":"Cell Death Differ"},{"key":"8888_CR49","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1073\/pnas.1909879116","volume":"117","author":"CJ Lee","year":"2020","unstructured":"Lee CJ, An HJ, Kim SM, Yoo SM, Park J, Lee GE, et al. FBXW7-mediated stability regulation of signal transducer and activator of transcription 2 in melanoma formation. Proc Natl Acad Sci USA. 2020;117:584\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8888_CR50","doi-asserted-by":"publisher","first-page":"28488","DOI":"10.1074\/jbc.M113.465179","volume":"288","author":"K Yumimoto","year":"2013","unstructured":"Yumimoto K, Matsumoto M, Onoyama I, Imaizumi K, Nakayama KI. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation. J Biol Chem. 2013;288:28488\u2013502.","journal-title":"J Biol Chem"},{"key":"8888_CR51","doi-asserted-by":"publisher","first-page":"14930","DOI":"10.1096\/fj.202001340R","volume":"34","author":"S Hoshikawa","year":"2020","unstructured":"Hoshikawa S, Shimizu K, Watahiki A, Chiba M, Saito K, Wei W, et al. Phosphorylation-dependent osterix degradation negatively regulates osteoblast differentiation. FASEB J. 2020;34:14930\u201345.","journal-title":"FASEB J"},{"key":"8888_CR52","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1074-7613(00)00077-7","volume":"13","author":"C Park","year":"2000","unstructured":"Park C, Li S, Cha E, Schindler C. Immune response in Stat2 knockout mice. Immunity. 2000;13:795\u2013804.","journal-title":"Immunity"},{"key":"8888_CR53","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","volume":"89","author":"T Komori","year":"1997","unstructured":"Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755\u201364.","journal-title":"Cell"},{"key":"8888_CR54","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","volume":"89","author":"P Ducy","year":"1997","unstructured":"Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747\u201354.","journal-title":"Cell"},{"key":"8888_CR55","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/mt.2011.101","volume":"19","author":"L Lin","year":"2011","unstructured":"Lin L, Shen Q, Leng H, Duan X, Fu X, Yu C. Synergistic inhibition of endochondral bone formation by silencing Hif1alpha and Runx2 in trauma-induced heterotopic ossification. Mol Ther. 2011;19:1426\u201332.","journal-title":"Mol Ther"},{"key":"8888_CR56","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.omtm.2020.04.010","volume":"17","author":"YS Yang","year":"2020","unstructured":"Yang YS, Xie J, Chaugule S, Wang D, Kim JM, Kim J, et al. Bone-targeting AAV-mediated gene silencing in osteoclasts for osteoporosis therapy. Mol Ther Methods Clin Dev. 2020;17:922\u201335.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"8888_CR57","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.ymthe.2017.03.028","volume":"25","author":"J Xie","year":"2017","unstructured":"Xie J, Mao Q, Tai PWL, He R, Ai J, Su Q, et al. Short DNA hairpins compromise recombinant adeno-associated virus genome homogeneity. Mol Ther. 2017;25:1363\u201374.","journal-title":"Mol Ther"},{"key":"8888_CR58","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Min Res. 2010;25:1468\u201386.","journal-title":"J Bone Min Res"},{"key":"8888_CR59","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/s41418-022-00952-x","volume":"29","author":"JM Kim","year":"2022","unstructured":"Kim JM, Yang YS, Xie J, Lee O, Kim J, Hong J, et al. Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes. Cell Death Differ. 2022;29:1625\u201338.","journal-title":"Cell Death Differ"},{"key":"8888_CR60","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Min Res. 1987;2:595\u2013610.","journal-title":"J Bone Min Res"},{"key":"8888_CR61","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Min Res. 2013;28:2\u201317.","journal-title":"J Bone Min Res"},{"key":"8888_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ab.2004.02.002","volume":"329","author":"CA Gregory","year":"2004","unstructured":"Gregory CA, Gunn WG, Peister A, Prockop DJ. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem. 2004;329:77\u201384.","journal-title":"Anal Biochem"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08888-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08888-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08888-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:02:57Z","timestamp":1785758577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08888-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8888"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08888-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JHS is a scientific co-founder of the AAVAA Therapeutics and holds equity in this company. GG is a scientific co-founder of AAVAA Therapeutics, Voyager Therapeutics, and Aspa Therapeutics and holds equity in these companies. GG is an inventor on patents with potential royalties licensed to Voyager Therapeutics, Aspa Therapeutics Inc., and other biopharmaceutical companies. Other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animals were used in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were handled according to protocols approved by the University of Massachusetts Chan Medical School on Animal Care (IACUC, Approval #202200036).","order":2,"name":"Ethics","label":"ETHICS","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"675"}}